Development of monoclonal antibody against Norfloxacin

LIU Qing-tang,ZHI Ai-min,LI Qing-mei,CHAI Shu-jun,ZHAO Dong,ZHANG Lei,DENG Rui-guang,ZHANG Gai-ping
DOI: https://doi.org/10.3969/j.issn.1008-0589.2010.09.14
2010-01-01
Abstract:Monoclonal antibody (MAb) directed against Norfloxacin was developed by fusion of myeloma cells with spleen cells obtained from mice immunized with BSA coupled norfloxacin antigen (BSA-NFLX). Two hybridoma cell lines,3C6 and 3G11 that secret MAb specific for NFLX were established. The titer of the MAb determined by indirect ELISA were 1 ∶512 in supernatant and 1∶6.4×105 in ascites,repectively. The MAb secreted by 3C6 showed an IC50 of 2.52 μg/L and had less than 0.03% cross-reactivity with difloxain and sarafloxacin. This MAb has a high titer and is specific and highly sensitive which could be used for immunoassays to detect NFLX residues.
What problem does this paper attempt to address?